Antihemorrhagics, antifibrinolytics, amino acids. Fibrinolysis inhibitors. ATC Code B02A A02

Indications to Use:

Bleeding or risk of bleeding with increased fibrinolysis, both generalized and local: menorrhagia, metrorrhagia, nasal, pulmonary, gastrointestinal bleeding, hematuria, bleeding during and after operations on the prostate gland, organs of the urinary tract, ENT organs (adenoidectomy, tonsillectomy, extraction of teeth), on the organs of the thoracic and abdominal cavities, during and after gynecological operations, obstetric manipulations and other surgical interventions, in cardiovascular surgery, bleeding with pregnancy postpartum bleeding, manual detachment, chorion-free prescription, malignant neoplasm of the pancreas and prostate gland, hemophilia, bleeding after prostatectomy, conization of the cervix for carcinoma, thrombocytopenic purpura, leukemia, liver disease, previous therapy with streptokinase. Surgical manipulations at a systemic inflammatory reaction (sepsis, peritonitis, pancreatic necrosis, severe and moderate severity of gestosis, shock of various etiologies and other critical conditions). Hemorrhagic complications in fibrinolytic therapy.